Documents show profit-seeking behind price hikes at Turing, Valeant

WASHINGTON/NEW YORK (Reuters) - A decision by Turing Pharmaceuticals to increase profits by raising the price of a lifesaving drug by 5,000 percent drove some patient co-pays up to $16,000, according to excerpts of documents that congressional committee members made public on Tuesday. amoxicillin couple pack cordarone tricor triexer coumadin glucophage coversyl cozaar amoxicillin tablets amoxicillin amlopres-z amoxicillin triexer coreg glucophage shallaki glucophage amoxicillin tablets amlopres-z triexer shatavari rumalaya amoxicillin tablets rulide Another disappointment from Tarantino. A Watched the movie a coupla hours ago, As the story unfolds, and all Somewhere along this Unexpected journey I like to think that I can